Types of Work

["2024"]

[[["Meeting Abstracts",1261],["Journal Articles",1061],["Reviews",108],["Editorials",54],["Research Letters",31],["Book Sections",22],["Correspondences",21],["Guidelines",12],["Conference Papers",2],["Miscellaneous",1]]]

[2573]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• genetics
• human
• humans
• major clinical study
• male

Recent Works

1. Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

   Correspondence

   Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
   Blood Cancer Journal (2025)

   Fulltext@MSK | Save
2. Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1

   Meeting Abstract

   Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save
3. SUPRAME: A phase 3 trial comparing IMA203, an engineered T-cell receptor expressing T cell therapy (TCR-T) vs investigator's choice in patients with previously treated advanced cutaneous melanoma

   Meeting Abstract

   Luke, J. J.; Warner, A. B.; Chmielowski, B.; Diab, A.; Gebhardt, C.; Hernandez-Aya, L. F.; Hu-Lieskovan, S.; Karapetyan, L.; Lawrence, D. P.; McKean, M.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save